IOL Chemicals and Pharmaceuticals Limited
NCVI Enterprises Limited, a promoter group entity, bought 404,305 shares of IOL Chemicals and Pharmaceuticals Limited for ₹3.01 Cr at ₹74.56 apiece on March 19, 2026, increasing its stake from 16.44% to 16.58%. This transaction was an insider filing under Regulation 7(2).
A leading pharmaceutical company, IOL Chemicals manufactures active pharmaceutical ingredients and specialty chemicals for both domestic and international markets. The company serves pharmaceutical manufacturers, agrochemical producers, and other industrial clients across multiple sectors. Its integrated operations span chemical synthesis, process development, quality assurance, and regulatory compliance. IOL Chemicals maintains manufacturing facilities equipped with advanced technology to ensure product quality and consistency across its diverse portfolio.